SlideShare une entreprise Scribd logo
1  sur  23
Ramachandra
IVT refers
 structurally normal hearts.
 Young patients
 Benign course
 focal
 Monomorphic
 No scar
 12-lead ECG extremely useful
 Treatment :reassurance, medical therapy, and
catheter ablation.
 Prevalence estimates accounted for 7%-38% of all
patients referred for VT
 Realistic estimation is closer to 10%.
 RVOT Tachycardia
 LVOT/Aortic Cusp Tachycardia
 Epicardial Outflow Tract VT
Mechanism
triggered activity due to catecholamine-mediated delayed after-depolarizations.This
triggered activity results from a catecholamine-mediated increase in cyclic adenosine
monophosphate, with subsequent increase in intracellular calcium from the sarcoplasmic
reticulum, resulting in delayed after-depolarizations and triggered activity. This underlying
mechanism leads to tachycardia initiation with catecholamines and termination with
adenosine, -blockers, or calcium channel blockers.
 most common IPVT-70%
 LBBB/Inf axis
 F>X2M
 triggered by exercise or stress, and may also occur
during hormonal cycles in women
 third to fifth decade of life
 C/F: palpitations/chest pain, fatigue, and
presyncope or syncope/isolated PVCs/nonsustained
VT/sustained VT.
 10%-15% of IPVT,M>F
 Anatomy
Noncoronary cusp does not directly contactventricular
myocardium, ventricular arrhythmias are rare.
The base of the left and right coronary cusps lies in direct
contact to the ventricular myocardium, and LV muscle fibers
may extend into the aortic root,serving as a source of these
PVCs. These extensions may be a remnant from embryonic
development, and these myocardial fibers persist providing an
arrhythmogenic substrate. When mapping more inferiorly in
the aortic root, successful ablation may be related to necrosis
of ventricular myocytes arising from the most superior portion
of the ostium of the LV.
LBBB /inferior axis/ precordial transition earlier than
their RVOT-VT . The precordial R-wave transition
typically occurs at or before lead V3. VT originating
from the left.coronary cusp has an earlier R-wave
transition (typically by V1/2) than the right
coronary cusp (V2/3). A broader R-wave duration
(_0.5 ms) and a taller R/S-wave Amplitude in V1
and V2 favor aortic cusp location.When the
precordial transition occurs at lead V3, a precordial
transition earlier than sinus rhythm transition is
suggestive of LVOT-VT.
 Idiopathic left fascicular VT= fascicular VT=LBB-
ANT/POST
 ECG classify to left posterior fascicular VT, left anterior
fascicular VT, and left upper septal VT.
 LPFVT- most common then LAFVT & septal is rare
 young male(60%)- 15 and 40 years, younger female.
 paroxysmal
 Exertion.
 Symptoms – palpitations/syncope /tachycardia-
mediated cardiomyopathy .
 RBBB/LAD/ VT induced by atria pacing.
 Verapamil sensitive
 tachycardia originates from the Purkinje network of the
 mechanism of verapamil-sensitive left VT is
reentry/induced, entrained, and terminated by
ventricular or atrial stimulation. The proposed
reentrant circuit consists of an area of slow conduction
that forms the orthodromic limb in the LV septum from
base to apex, with the retrograde limb using the
Purkinje network
 false tendons is arrythmogenic.
 RBBB/left superior axis pattern/narrow/confused
for SVT
 LPFT - RBBB and left axis deviation(LAFB)
 LAFT-RBBB/RAD(LFBB)
 septal VT demonstrates an incomplete
RBBB and normal axis.
 Excellent prognosis
 Medical Therapy
Intravenous verapamil is effective for acute termination.
Chronic oral verapamil therapy is often an effective regimen
for patients with symptoms who do not wish to pursue
catheter ablation.-adrenergic blockers have also been used
with some success.
 Catheter Ablation: successful-90%,
 2008, Doppalapudi et al. first to report idiopathic VT from posterior
PM
 Posterior papillary muscle origin is more common.
Papillary muscle VT is usually exercise induced and is catecholamine
sensitive, requiring isoproterenol or epinephrine for induction
 mechanism is typically focal in nature and not reentrant. This VT cannot
be entrained, and has a lack of late potentials at the site of ablation.
 Papillary muscle VT often exhibits multiple QRS morphologies, with
subtle changes seen spontaneously or during ablation. These subtle
morphologic changes are thought to be from preferential conduction to
different exit sites or multiple regions of origins within the complex
structure of the papillary muscles.
 RFA-quite usuful.
 majority from anterior mitral annulus
 ECG in MAVT:RBBB pattern/ monophasic R or Rs in
leads V2-V6.
 Catheter ablation is highly successful with ablation
delivered at the site of earliest ventricular
activation or sites with a 12/12 pace-map match by
mostly endocardial approach or coronary venous
system(GCV)
 8% of IPVT
 5% of right-sided VT
 Septal sites > free-wall sites
 septal locations-anteroseptal or para-Hisian.
 ECG: A positive component (any r or R) was recorded in lead aVL in 95%
of patients
 QRS duration and Q-wave amplitude V1-V3 were greater in VT/PVCs
arising from the free wall of the tricuspid annulus compared with the
septum. Notching of the QRS complex was seen more often in free-wall
sites, as well as later precordial transition. A Q-wave in lead V1 was
observed more often in septal tricuspid annular VTs.
 RF catheter ablation successful for the free wall (90%) compared with
the septal (57%) group. Low success rate in the septal tricuspid annular
group was thought to be due to the likelihood of impairing AV nodal
conduction with RF ablation.
 Van Herendael reported 278 IPVT from
10% -lower RV body.
48% -Within 2 cm of the tricuspid annulus
28% -Basal RV
24% -the apical RV.
 VT/PVC from the RV free wall had a longer QRS
duration and deeper S-wave in lead V2/V3.
 Apical VT/PVC more often had precordial R-wave
transition V6, smaller R-waves in lead II, and an S-wave
in aVR.
 RF catheter ablation was acutely successful in 96% of
patients.
 Doppalapudi described 4/340 patients referred for IPVT
 Epicardial , junction of the middle cardiac vein and the coronary sinus
 Sustained / syncope or presyncope
 Induced/timulation or burst pacing from the RV, and often required
Isoproterenol
 ECG demonstrates a leftward superior axis QRS
morphology with an early precordial transition and delayed intrinsicoid
deflection.
 EP study: The earliest activation was present in the middle cardiac vein.
Coronary angiography
demonstrated the site of earliest activation within 5-10 mm of the
proximal posterior descending artery or proximal coronary sinus
 Ablation from the coronary sinus or middle cardiac vein was attempted
in all, but was successful in only one.Percutaneous epicardial ablation
was attempted in two of the remaining three, and successfully
abolished VT in both.
Idiopathic ventricular tachycardia

Contenu connexe

Tendances

Eps basics,part2(lecture)
Eps basics,part2(lecture)Eps basics,part2(lecture)
Eps basics,part2(lecture)salah_atta
 
ventricular tachycardia (VT) Localisation
ventricular tachycardia (VT) Localisationventricular tachycardia (VT) Localisation
ventricular tachycardia (VT) LocalisationMalleswara rao Dangeti
 
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATIONECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATIONPraveen Nagula
 
WPW EP evaluation
WPW EP evaluationWPW EP evaluation
WPW EP evaluationRohitWalse2
 
Ep diagnosis and ablation of avnrt
Ep diagnosis and ablation of avnrtEp diagnosis and ablation of avnrt
Ep diagnosis and ablation of avnrtRahul Chalwade
 
Echo assesment of rv function
Echo assesment of rv function Echo assesment of rv function
Echo assesment of rv function Nizam Uddin
 
Basic EP study (part1)
Basic  EP  study (part1)Basic  EP  study (part1)
Basic EP study (part1)SolidaSakhan
 
How to echo... tricuspid regurgitation.ppt
How to echo... tricuspid regurgitation.pptHow to echo... tricuspid regurgitation.ppt
How to echo... tricuspid regurgitation.pptVinayak Vadgaonkar
 
Echocardiographic Evaluation of Hypertrophic Cardiomyopathy
Echocardiographic Evaluation of Hypertrophic CardiomyopathyEchocardiographic Evaluation of Hypertrophic Cardiomyopathy
Echocardiographic Evaluation of Hypertrophic CardiomyopathyHatem Soliman Aboumarie
 
Congenital Heart Disease An Approach for Simple and Complex Anomalies
Congenital Heart Disease An Approach for Simple and Complex AnomaliesCongenital Heart Disease An Approach for Simple and Complex Anomalies
Congenital Heart Disease An Approach for Simple and Complex AnomaliesNizam Uddin
 
Echocardiography assessment of Aortic Regurgitation severity
Echocardiography assessment of Aortic Regurgitation severityEchocardiography assessment of Aortic Regurgitation severity
Echocardiography assessment of Aortic Regurgitation severityPRAVEEN GUPTA
 
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATIONECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATIONPraveen Nagula
 
Cardiac resynchronization therapy
Cardiac resynchronization therapyCardiac resynchronization therapy
Cardiac resynchronization therapyJose Osorio
 

Tendances (20)

9.avnrt chang sl-0324-2
9.avnrt chang sl-0324-29.avnrt chang sl-0324-2
9.avnrt chang sl-0324-2
 
Eps basics,part2(lecture)
Eps basics,part2(lecture)Eps basics,part2(lecture)
Eps basics,part2(lecture)
 
Electrophysiology AVNRT
Electrophysiology AVNRTElectrophysiology AVNRT
Electrophysiology AVNRT
 
ventricular tachycardia (VT) Localisation
ventricular tachycardia (VT) Localisationventricular tachycardia (VT) Localisation
ventricular tachycardia (VT) Localisation
 
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATIONECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
 
WPW EP evaluation
WPW EP evaluationWPW EP evaluation
WPW EP evaluation
 
Echo assessment of RV function
Echo assessment of RV functionEcho assessment of RV function
Echo assessment of RV function
 
Ep diagnosis and ablation of avnrt
Ep diagnosis and ablation of avnrtEp diagnosis and ablation of avnrt
Ep diagnosis and ablation of avnrt
 
Echo assesment of rv function
Echo assesment of rv function Echo assesment of rv function
Echo assesment of rv function
 
Basic EP study (part1)
Basic  EP  study (part1)Basic  EP  study (part1)
Basic EP study (part1)
 
Sinus of valsalva aneurysm
Sinus of valsalva aneurysmSinus of valsalva aneurysm
Sinus of valsalva aneurysm
 
ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE
ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE
ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE
 
How to echo... tricuspid regurgitation.ppt
How to echo... tricuspid regurgitation.pptHow to echo... tricuspid regurgitation.ppt
How to echo... tricuspid regurgitation.ppt
 
Echocardiographic Evaluation of Hypertrophic Cardiomyopathy
Echocardiographic Evaluation of Hypertrophic CardiomyopathyEchocardiographic Evaluation of Hypertrophic Cardiomyopathy
Echocardiographic Evaluation of Hypertrophic Cardiomyopathy
 
POST CRT OPTIMISATION
POST CRT OPTIMISATIONPOST CRT OPTIMISATION
POST CRT OPTIMISATION
 
Congenital Heart Disease An Approach for Simple and Complex Anomalies
Congenital Heart Disease An Approach for Simple and Complex AnomaliesCongenital Heart Disease An Approach for Simple and Complex Anomalies
Congenital Heart Disease An Approach for Simple and Complex Anomalies
 
Echocardiography assessment of Aortic Regurgitation severity
Echocardiography assessment of Aortic Regurgitation severityEchocardiography assessment of Aortic Regurgitation severity
Echocardiography assessment of Aortic Regurgitation severity
 
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATIONECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
 
Cardiac dyssynchrony ppt by dr awadhesh
Cardiac dyssynchrony ppt   by dr awadheshCardiac dyssynchrony ppt   by dr awadhesh
Cardiac dyssynchrony ppt by dr awadhesh
 
Cardiac resynchronization therapy
Cardiac resynchronization therapyCardiac resynchronization therapy
Cardiac resynchronization therapy
 

En vedette

Out Flow tract VT, Diagnostic Tools and Ablation Weapons
Out Flow tract VT, Diagnostic Tools and Ablation WeaponsOut Flow tract VT, Diagnostic Tools and Ablation Weapons
Out Flow tract VT, Diagnostic Tools and Ablation WeaponsDr.Mahmoud Abbas
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardiaPraveen Nagula
 
Management of ventricular tachyarrythmias
Management of ventricular tachyarrythmiasManagement of ventricular tachyarrythmias
Management of ventricular tachyarrythmiasDebajyoti Chakraborty
 
tachyarrythmias d
tachyarrythmias dtachyarrythmias d
tachyarrythmias dRavi Kanth
 
Dr. J.L. Mont Girbau: ¿Cómo reducir las descargas en pacientes portadores de ...
Dr. J.L. Mont Girbau: ¿Cómo reducir las descargas en pacientes portadores de ...Dr. J.L. Mont Girbau: ¿Cómo reducir las descargas en pacientes portadores de ...
Dr. J.L. Mont Girbau: ¿Cómo reducir las descargas en pacientes portadores de ...Sociedad Española de Cardiología
 
Brugada Syndrome and LQTS - the evidence
Brugada Syndrome and LQTS - the evidenceBrugada Syndrome and LQTS - the evidence
Brugada Syndrome and LQTS - the evidenceJunhao Koh
 
Mechanism of arrythmias
Mechanism of arrythmiasMechanism of arrythmias
Mechanism of arrythmiasSachin Sondhi
 

En vedette (20)

Out Flow tract VT, Diagnostic Tools and Ablation Weapons
Out Flow tract VT, Diagnostic Tools and Ablation WeaponsOut Flow tract VT, Diagnostic Tools and Ablation Weapons
Out Flow tract VT, Diagnostic Tools and Ablation Weapons
 
ECG: Fascicular VT
ECG: Fascicular VTECG: Fascicular VT
ECG: Fascicular VT
 
Catheter ablation of ventricular tachycardia
Catheter ablation of ventricular tachycardiaCatheter ablation of ventricular tachycardia
Catheter ablation of ventricular tachycardia
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
Management of ventricular tachyarrythmias
Management of ventricular tachyarrythmiasManagement of ventricular tachyarrythmias
Management of ventricular tachyarrythmias
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
Ventricular arrhythmias
Ventricular arrhythmias Ventricular arrhythmias
Ventricular arrhythmias
 
EP diagnosis of WIDE COMPLEX TACHYCARDIA
EP diagnosis of WIDE COMPLEX TACHYCARDIAEP diagnosis of WIDE COMPLEX TACHYCARDIA
EP diagnosis of WIDE COMPLEX TACHYCARDIA
 
Ventricular tachycardia_lecture
Ventricular tachycardia_lectureVentricular tachycardia_lecture
Ventricular tachycardia_lecture
 
tachyarrythmias d
tachyarrythmias dtachyarrythmias d
tachyarrythmias d
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
ECG: Wide Complex Tachycardia
ECG: Wide Complex TachycardiaECG: Wide Complex Tachycardia
ECG: Wide Complex Tachycardia
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
OSYPKA _EP-Products kopie
OSYPKA _EP-Products kopieOSYPKA _EP-Products kopie
OSYPKA _EP-Products kopie
 
MI-Presentation
MI-PresentationMI-Presentation
MI-Presentation
 
Dr. J.L. Mont Girbau: ¿Cómo reducir las descargas en pacientes portadores de ...
Dr. J.L. Mont Girbau: ¿Cómo reducir las descargas en pacientes portadores de ...Dr. J.L. Mont Girbau: ¿Cómo reducir las descargas en pacientes portadores de ...
Dr. J.L. Mont Girbau: ¿Cómo reducir las descargas en pacientes portadores de ...
 
Repolarization syndromes
Repolarization syndromesRepolarization syndromes
Repolarization syndromes
 
Brugada Syndrome and LQTS - the evidence
Brugada Syndrome and LQTS - the evidenceBrugada Syndrome and LQTS - the evidence
Brugada Syndrome and LQTS - the evidence
 
Mechanism of arrythmias
Mechanism of arrythmiasMechanism of arrythmias
Mechanism of arrythmias
 
Updates in ACLS 2005
Updates in ACLS 2005Updates in ACLS 2005
Updates in ACLS 2005
 

Similaire à Idiopathic ventricular tachycardia

Similaire à Idiopathic ventricular tachycardia (20)

Wide complex tachycardia
Wide complex tachycardiaWide complex tachycardia
Wide complex tachycardia
 
TACHYARRHYTHMIA
TACHYARRHYTHMIATACHYARRHYTHMIA
TACHYARRHYTHMIA
 
Tachyarrhythmia
TachyarrhythmiaTachyarrhythmia
Tachyarrhythmia
 
Supra ventri cular arrhythmia 2021
Supra ventri cular arrhythmia  2021Supra ventri cular arrhythmia  2021
Supra ventri cular arrhythmia 2021
 
Idiopathic Ventricular Tachycardia (VT)
Idiopathic Ventricular Tachycardia (VT)Idiopathic Ventricular Tachycardia (VT)
Idiopathic Ventricular Tachycardia (VT)
 
Approach to svt
Approach to svt Approach to svt
Approach to svt
 
Basic of Pre-excitation syndrome
Basic of Pre-excitation syndromeBasic of Pre-excitation syndrome
Basic of Pre-excitation syndrome
 
Avrt and avnrt
Avrt and avnrtAvrt and avnrt
Avrt and avnrt
 
Supraventricular tachycardias
Supraventricular tachycardiasSupraventricular tachycardias
Supraventricular tachycardias
 
Dr nigat
Dr nigatDr nigat
Dr nigat
 
Avrt vz vt
Avrt vz vtAvrt vz vt
Avrt vz vt
 
Wolf Parkinson Syndrome By Dr Hasan Mahmud.
Wolf Parkinson Syndrome By Dr Hasan Mahmud.Wolf Parkinson Syndrome By Dr Hasan Mahmud.
Wolf Parkinson Syndrome By Dr Hasan Mahmud.
 
Ekg Cases 7 15 09 Level 2 Part 1
Ekg Cases 7 15 09 Level 2 Part 1Ekg Cases 7 15 09 Level 2 Part 1
Ekg Cases 7 15 09 Level 2 Part 1
 
L-TGA or CCTGA
L-TGA or CCTGA L-TGA or CCTGA
L-TGA or CCTGA
 
Wide complex tachycardia
Wide complex tachycardiaWide complex tachycardia
Wide complex tachycardia
 
ECG - Narrow complex tachycardia
ECG - Narrow complex tachycardiaECG - Narrow complex tachycardia
ECG - Narrow complex tachycardia
 
AVNRT
AVNRTAVNRT
AVNRT
 
WIDE COMPLEX TACHYCARDIA DR PRADEEP.ppsx
WIDE COMPLEX TACHYCARDIA DR  PRADEEP.ppsxWIDE COMPLEX TACHYCARDIA DR  PRADEEP.ppsx
WIDE COMPLEX TACHYCARDIA DR PRADEEP.ppsx
 
Vt in normal and abnormal hearts my ppt copy
Vt in normal and abnormal hearts my ppt   copyVt in normal and abnormal hearts my ppt   copy
Vt in normal and abnormal hearts my ppt copy
 
VT-diagnosis.ppt
VT-diagnosis.pptVT-diagnosis.ppt
VT-diagnosis.ppt
 

Plus de Ramachandra Barik

Intensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptxIntensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptxRamachandra Barik
 
Management of Hypetension.pptx
Management of Hypetension.pptxManagement of Hypetension.pptx
Management of Hypetension.pptxRamachandra Barik
 
CRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdfCRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdfRamachandra Barik
 
Pacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After SplenectomyPacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After SplenectomyRamachandra Barik
 
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...Ramachandra Barik
 
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...Ramachandra Barik
 
Anticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancyAnticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancyRamachandra Barik
 
Intracoronary optical coherence tomography
Intracoronary optical coherence tomographyIntracoronary optical coherence tomography
Intracoronary optical coherence tomographyRamachandra Barik
 
A roadmap for the human development
A roadmap for the human developmentA roadmap for the human development
A roadmap for the human developmentRamachandra Barik
 
Left ventricular false tendons
Left ventricular false tendonsLeft ventricular false tendons
Left ventricular false tendonsRamachandra Barik
 

Plus de Ramachandra Barik (20)

Willens's syndrome.pptx
Willens's syndrome.pptxWillens's syndrome.pptx
Willens's syndrome.pptx
 
Intensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptxIntensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptx
 
Management of Hypetension.pptx
Management of Hypetension.pptxManagement of Hypetension.pptx
Management of Hypetension.pptx
 
CRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdfCRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdf
 
Pacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After SplenectomyPacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After Splenectomy
 
Piccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdfPiccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdf
 
MISPLACED ECG LEADS.pptx
MISPLACED ECG LEADS.pptxMISPLACED ECG LEADS.pptx
MISPLACED ECG LEADS.pptx
 
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
 
Arrythmia-IV.pptx
Arrythmia-IV.pptxArrythmia-IV.pptx
Arrythmia-IV.pptx
 
Arrythmia-III.pptx
Arrythmia-III.pptxArrythmia-III.pptx
Arrythmia-III.pptx
 
Arrythmia-II.pptx
Arrythmia-II.pptxArrythmia-II.pptx
Arrythmia-II.pptx
 
Arrythmia-I.pptx
Arrythmia-I.pptxArrythmia-I.pptx
Arrythmia-I.pptx
 
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
 
Anticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancyAnticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancy
 
Coronary guidewire
Coronary guidewireCoronary guidewire
Coronary guidewire
 
Intracoronary optical coherence tomography
Intracoronary optical coherence tomographyIntracoronary optical coherence tomography
Intracoronary optical coherence tomography
 
Brugada syndrome
Brugada syndromeBrugada syndrome
Brugada syndrome
 
A roadmap for the human development
A roadmap for the human developmentA roadmap for the human development
A roadmap for the human development
 
Intra aortic balloon pump
Intra aortic balloon pumpIntra aortic balloon pump
Intra aortic balloon pump
 
Left ventricular false tendons
Left ventricular false tendonsLeft ventricular false tendons
Left ventricular false tendons
 

Dernier

Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 

Dernier (20)

Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 

Idiopathic ventricular tachycardia

  • 2.
  • 3. IVT refers  structurally normal hearts.  Young patients  Benign course  focal  Monomorphic  No scar  12-lead ECG extremely useful  Treatment :reassurance, medical therapy, and catheter ablation.
  • 4.  Prevalence estimates accounted for 7%-38% of all patients referred for VT  Realistic estimation is closer to 10%.
  • 5.
  • 6.
  • 7.
  • 8.  RVOT Tachycardia  LVOT/Aortic Cusp Tachycardia  Epicardial Outflow Tract VT Mechanism triggered activity due to catecholamine-mediated delayed after-depolarizations.This triggered activity results from a catecholamine-mediated increase in cyclic adenosine monophosphate, with subsequent increase in intracellular calcium from the sarcoplasmic reticulum, resulting in delayed after-depolarizations and triggered activity. This underlying mechanism leads to tachycardia initiation with catecholamines and termination with adenosine, -blockers, or calcium channel blockers.
  • 9.  most common IPVT-70%  LBBB/Inf axis  F>X2M  triggered by exercise or stress, and may also occur during hormonal cycles in women  third to fifth decade of life  C/F: palpitations/chest pain, fatigue, and presyncope or syncope/isolated PVCs/nonsustained VT/sustained VT.
  • 10.  10%-15% of IPVT,M>F  Anatomy Noncoronary cusp does not directly contactventricular myocardium, ventricular arrhythmias are rare. The base of the left and right coronary cusps lies in direct contact to the ventricular myocardium, and LV muscle fibers may extend into the aortic root,serving as a source of these PVCs. These extensions may be a remnant from embryonic development, and these myocardial fibers persist providing an arrhythmogenic substrate. When mapping more inferiorly in the aortic root, successful ablation may be related to necrosis of ventricular myocytes arising from the most superior portion of the ostium of the LV.
  • 11. LBBB /inferior axis/ precordial transition earlier than their RVOT-VT . The precordial R-wave transition typically occurs at or before lead V3. VT originating from the left.coronary cusp has an earlier R-wave transition (typically by V1/2) than the right coronary cusp (V2/3). A broader R-wave duration (_0.5 ms) and a taller R/S-wave Amplitude in V1 and V2 favor aortic cusp location.When the precordial transition occurs at lead V3, a precordial transition earlier than sinus rhythm transition is suggestive of LVOT-VT.
  • 12.
  • 13.  Idiopathic left fascicular VT= fascicular VT=LBB- ANT/POST  ECG classify to left posterior fascicular VT, left anterior fascicular VT, and left upper septal VT.  LPFVT- most common then LAFVT & septal is rare  young male(60%)- 15 and 40 years, younger female.  paroxysmal  Exertion.  Symptoms – palpitations/syncope /tachycardia- mediated cardiomyopathy .
  • 14.
  • 15.  RBBB/LAD/ VT induced by atria pacing.  Verapamil sensitive  tachycardia originates from the Purkinje network of the  mechanism of verapamil-sensitive left VT is reentry/induced, entrained, and terminated by ventricular or atrial stimulation. The proposed reentrant circuit consists of an area of slow conduction that forms the orthodromic limb in the LV septum from base to apex, with the retrograde limb using the Purkinje network  false tendons is arrythmogenic.
  • 16.  RBBB/left superior axis pattern/narrow/confused for SVT  LPFT - RBBB and left axis deviation(LAFB)  LAFT-RBBB/RAD(LFBB)  septal VT demonstrates an incomplete RBBB and normal axis.
  • 17.  Excellent prognosis  Medical Therapy Intravenous verapamil is effective for acute termination. Chronic oral verapamil therapy is often an effective regimen for patients with symptoms who do not wish to pursue catheter ablation.-adrenergic blockers have also been used with some success.  Catheter Ablation: successful-90%,
  • 18.  2008, Doppalapudi et al. first to report idiopathic VT from posterior PM  Posterior papillary muscle origin is more common. Papillary muscle VT is usually exercise induced and is catecholamine sensitive, requiring isoproterenol or epinephrine for induction  mechanism is typically focal in nature and not reentrant. This VT cannot be entrained, and has a lack of late potentials at the site of ablation.  Papillary muscle VT often exhibits multiple QRS morphologies, with subtle changes seen spontaneously or during ablation. These subtle morphologic changes are thought to be from preferential conduction to different exit sites or multiple regions of origins within the complex structure of the papillary muscles.  RFA-quite usuful.
  • 19.  majority from anterior mitral annulus  ECG in MAVT:RBBB pattern/ monophasic R or Rs in leads V2-V6.  Catheter ablation is highly successful with ablation delivered at the site of earliest ventricular activation or sites with a 12/12 pace-map match by mostly endocardial approach or coronary venous system(GCV)
  • 20.  8% of IPVT  5% of right-sided VT  Septal sites > free-wall sites  septal locations-anteroseptal or para-Hisian.  ECG: A positive component (any r or R) was recorded in lead aVL in 95% of patients  QRS duration and Q-wave amplitude V1-V3 were greater in VT/PVCs arising from the free wall of the tricuspid annulus compared with the septum. Notching of the QRS complex was seen more often in free-wall sites, as well as later precordial transition. A Q-wave in lead V1 was observed more often in septal tricuspid annular VTs.  RF catheter ablation successful for the free wall (90%) compared with the septal (57%) group. Low success rate in the septal tricuspid annular group was thought to be due to the likelihood of impairing AV nodal conduction with RF ablation.
  • 21.  Van Herendael reported 278 IPVT from 10% -lower RV body. 48% -Within 2 cm of the tricuspid annulus 28% -Basal RV 24% -the apical RV.  VT/PVC from the RV free wall had a longer QRS duration and deeper S-wave in lead V2/V3.  Apical VT/PVC more often had precordial R-wave transition V6, smaller R-waves in lead II, and an S-wave in aVR.  RF catheter ablation was acutely successful in 96% of patients.
  • 22.  Doppalapudi described 4/340 patients referred for IPVT  Epicardial , junction of the middle cardiac vein and the coronary sinus  Sustained / syncope or presyncope  Induced/timulation or burst pacing from the RV, and often required Isoproterenol  ECG demonstrates a leftward superior axis QRS morphology with an early precordial transition and delayed intrinsicoid deflection.  EP study: The earliest activation was present in the middle cardiac vein. Coronary angiography demonstrated the site of earliest activation within 5-10 mm of the proximal posterior descending artery or proximal coronary sinus  Ablation from the coronary sinus or middle cardiac vein was attempted in all, but was successful in only one.Percutaneous epicardial ablation was attempted in two of the remaining three, and successfully abolished VT in both.